Abstract

ABSTRACT

Background

Peritoneal dialysis (PD)-related peritonitis is a major complication of PD. Wide variations in peritonitis prevention, treatment strategies and consequences are seen between countries. These between-country differences may result from modifiable risk factors and clinical practices.

Methods

A total of 1225 Japanese PD patients were included and prospectively followed in the Peritoneal Dialysis Outcomes and Practice Patterns Study phase 1 (2014–2018) and phase 2 (2018–2022). Associations between PD-related peritonitis and various risk factors were assessed by Cox proportional hazards survival models.

Results

During follow-up (median 1.52 years), 539 peritonitis episodes were experienced by 364 patients. The country crude peritonitis rate was 0.27 episodes/patient-year. In the fully adjusted model, noticeable patient-level factors associated with experiencing any peritonitis included age {hazard ratio [HR] 1.07 per 5-year increase [95% confidence interval (CI) 1.01–1.14]}, serum albumin level [HR 0.63 per 1 g/dl higher (95% CI 0.48–0.82)] and continuous ambulatory peritoneal dialysis (PD) [HR 1.31 versus automated PD (95% CI 1.05–1.63)]. The adoption of antibiotic prophylaxis practice at the time of PD catheter insertion [HR 0.63 (95% CI 0.51–0.78)] or when having complicated dental procedures [HR 0.74 (95% CI 0.57–0.95)] or lower endoscopy [HR 0.69 (95% CI 0.54–0.89)] were associated with lower hazards of any peritonitis, while a routine facility practice of having more frequent regular medical visits was associated with a higher hazard.

Conclusion

Identification of risk factors in Japan may be useful for developing future versions of guidelines and improving clinical practices in Japan. Investigation of country-level risk factors for PD-related peritonitis is useful for developing and implementing local peritonitis prevention and treatment strategies

Details

Title
Risk factors of peritoneal dialysis–related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
Author
Ito, Yasuhiko 1   VIAFID ORCID Logo  ; Tu, Charlotte 2 ; Yamaguchi, Makoto 1 ; Koide, Shigehisa 3 ; Ryuzaki, Munekazu 4 ; Bieber, Brian 2 ; Pisoni, Ronald L 2 ; Perl, Jeffrey 5 ; Minakuchi, Jun 6 ; Kawanishi, Hideki 7 ; Tomo, Tadashi; Tsuchiya, Ken; Nitta, Kousaku; Fukazawa, Mizuya; Ito, Yasuhiro; Nakamoto, Hidetomo; Yamashita, Akihiro

 D epartment of Nephrology and Rheumatology, Aichi Medical University , Nagakute, Japan 
 Arbor Research Collaborative for Health , Ann Arbor, MI , USA 
 Fujita Health University , Toyoake , Japan 
 Saiseikai Chuou Hospital , Tokyo , Japan 
 St. Michael's Hospital , Toronto, ON , Canada 
 Kawashima Hospital , Tokushima , Japan 
 Tsuchiya General Hospital , Hiroshima , Japan 
Publication year
2024
Publication date
Jul 2024
Publisher
Oxford University Press
ISSN
20488505
e-ISSN
20488513
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3169669407
Copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the ERA. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.